$35.57
+0.84 (+2.42%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+22.6% upside
Low Target
$27.22
Average Target
$43.60
High Target
$49.94
Current Price
$35.57
Current
$35.57
$35.57
Target
$43.60
$43.60
$27.22
$43.60 avg
$49.94
Scenario Analysis
Bear Case
$27.22
-23.5%
Low target
Base Case
$43.60
+22.6%
Avg target
Bull Case
$49.94
+40.4%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$45.97
-22.6% from high
52-Week Low
$28.95
+22.9% from low
Target vs 52W High
$43.60
-5.2% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.16
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |